Cargando…
Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint
We have identified chemical probes that simultaneously inhibit cancer cell progression and an immune checkpoint. Using the computational Site Identification by Ligand Competitive Saturation (SILCS) technology, structural biology and cell-based assays, we identify small molecules that directly and se...
Autores principales: | Solano-Gonzalez, Eduardo, Coburn, Katherine M, Yu, Wenbo, Wilson, Gerald M, Nurmemmedov, Elmar, Kesari, Santosh, Chang, Elizabeth T, MacKerell, Alexander D, Weber, David J, Carrier, France |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897483/ https://www.ncbi.nlm.nih.gov/pubmed/33398344 http://dx.doi.org/10.1093/nar/gkaa1254 |
Ejemplares similares
-
(1)H, (13)C, and (15)N assignments of the mRNA binding protein hnRNP A18
por: Coburn, Katherine M., et al.
Publicado: (2022) -
Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells
por: Chang, Elizabeth T., et al.
Publicado: (2016) -
hnRNP A1 and hnRNP C associate with miR‐17 and miR‐18 in thyroid cancer cells
por: dos Santos, Maria Gabriela Pereira, et al.
Publicado: (2022) -
Paralogs hnRNP L and hnRNP LL Exhibit Overlapping but Distinct RNA Binding Constraints
por: Smith, Sarah A., et al.
Publicado: (2013) -
Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing
por: Martinez-Contreras, Rebeca, et al.
Publicado: (2006)